Trodelvy 180 MG Injection

RxCUI: 2360539
RxNorm name: Trodelvy 180 MG Injection
Display name: Trodelvy 180 MG Injection
Full name: Trodelvy 180 MG Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:59

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761115	Trodelvy	sacituzumab govitecan-hziy	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TRODELVY	SACITUZUMAB GOVITECAN	Gilead Sciences, Inc.	57a597d2-03f0-472e-b148-016d7169169d	2026-06-24	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2360539

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
57a597d2-03f0-472e-b148-016d7169169d	TRODELVY 180 MG Injection [PSN] · sacituzumab govitecan-hziy 180 MG Injection [Trodelvy] [SBD] · Trodelvy 180 MG Injection [SY]	3	18	These highlights do not include all the information needed to use TRODELVY safely and effectively. See full prescribing information for TRODELVY TRODELVY ® (sacituzumab govitecan-hziy) for injection, for intravenous use Initial U.S. Approval: 2020	20250331